1-6 of 6
Caspar da Cunha-Bang, MD PhD
Close
Sort by
Journal Articles

PreVent-ACaLL Short-term combined acalabrutinib and venetoclax treatment of newly diagnosed patients with CLL at high risk of infection and/or early treatment, who do not fulfil IWCLL treatment criteria for treatment. A randomized study with extensive immune phenotyping

Caspar Da Cunha-Bang, MD PhD, Rudy Agius, Arnon P. Kater, Mark-David Levin, MD PhD, Anders Österborg, MD PhD, Mattias Mattsson, MD, Carsten Utoft Niemann, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4304.
https://doi.org/10.1182/blood-2019-121907
Published: 2019
Journal Articles

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Emelie Curovic Rotbain, MD, Carsten Utoft Niemann, MD PhD Ass. Prof, Klaus Rostgaard, MSc., Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, MD Dr.MD, Henrik Frederiksen, MD Prof
Journal: Blood
Blood (2019) 134 (Supplement_1): 4285.
https://doi.org/10.1182/blood-2019-122673
Published: 2019
Journal Articles

Risk Factors Associated with Richter's Transformation in Patients with Chronic Lymphocytic Leukemia

Yasmin Ben-Dali, Mariam Hussein Hleuhel, MDcal student, Michael Asger Andersen, MD, Christian Brieghel, Erik Clasen-Linde, MD, Caspar Da Cunha-Bang, MD PhD, Carsten Utoft Niemann
Journal: Blood
Blood (2018) 132 (Supplement 1): 1697.
https://doi.org/10.1182/blood-2018-99-112442
Published: 2018
Journal Articles

Bacterial Infections in Patients with Chronic Lymphocytic Leukemia: A Longitudinal Nation-Wide Study

Michael Asger Andersen, MD, Caspar Da Cunha-Bang, MD PhD, Marie Helleberg, MD PhD, Carsten Utoft Niemann, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3461.
https://doi.org/10.1182/blood.V130.Suppl_1.3461.3461
Published: 2017
Journal Articles

IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis

Emelie Curovic Curovic Rotbain, MD, Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, Klaus Rostgaard, MSc., Michael A Andersen, MD, Carsten Utoft Niemann, MD PhD, Henrik Frederiksen, associate professor, consultant, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1742.
https://doi.org/10.1182/blood.V130.Suppl_1.1742.1742
Published: 2017
Journal Articles

Prognostic Impact of Subclonal TP53 Aberrations in Chronic Lymphocytic Leukemia Validated By a Robust Targeted Next Generation Sequencing Assay

Christian Brieghel, MD, Christina Westmose Yde, MSc, PhD, Caspar da Cunha-Bang, MD PhD, Savvas Kinalis, Data scientist, Lone Bredo Pedersen, Lars Jønson, MSc, PhD, Finn Cilius Nielsen, MD PhD, Carsten Utoft Niemann
Journal: Blood
Blood (2016) 128 (22): 4380.
https://doi.org/10.1182/blood.V128.22.4380.4380
Published: 2016